Hong Kong, March 24, 2026 – At the Hong Kong & Macau Regional Finals of the “Win in Suzhou • Create the Future” 2026 Global Entrepreneurship Competition, which concluded successfully today at The Wave in Wan Chai, Hong Kong, NutrigeneAI, a pioneer in cutting-edge iPSC-based regenerative therapies originating from The Chinese University of Hong Kong, delivered an outstanding performance. Led by its founder, Prof. Jack Wong (Wing-Tak Wong) from The Chinese University of Hong Kong, and Mr. Coby Ke, General Manager of its Shenzhen operations, the team’s groundbreaking project – the world’s first “Super Endothelial Cell Therapy for Treating Ischemic Diseases with Amputation Risk” based on iPSC technology – emerged victorious from intense competition among 205 entries, successfully securing the regionalVictory Award and a coveted spot in the Global Finals.
